Rigel Pharmaceuticals Inc (RIGL)
Cost of Revenue
$23.84M
TTM · Period ending: · USD
RIGL Cost of Revenue
Latest reported$23.84Mperiod ending
Latest reported$23.84Mperiod ending
RIGL Cost of Revenue (-$1.91M → $23.84M)
Annual cost of revenue
High-resolution chart · PNG
RIGL cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 19,621,000 | |
| 18,647,000 | |
| 7,110,000 | |
| 1,749,000 | |
| 1,083,000 | |
| 895,000 | |
| 906,000 | |
| 287,000 | |
| 46,269,000 | |
| 63,446,000 | |
| 62,825,000 | |
| 67,696,000 | |
| 75,328,000 | |
| 78,778,000 | |
| 0 | |
| 0 | |
| 1,403,000 | |
| 1,425,000 | |
| 0 | |
| 0 | |
| 1,150,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -7,557,000 | |
| -1,906,000 |